top of page

TREAT(ment) for man's best friend.

Despite significant advancements in human biotherapeutics, canine treatments lag far behind. 

We intend to close that gap.

Vision

We are Treat Biosciences, a team founded by veterans in biotech with years of experience. We envision a future where every pet enjoys a longer, healthier life through cutting-edge biotechnology and compassionate care. We aim to revolutionize veterinary medicine by translating advanced human therapeutics into effective, accessible treatments for canines. 

Why We TREAT Canine Cancer

The high incidence of canine cancer and the ever-increasing cost of treatment compel us to create more effective, and affordable drugs for TREATing cancer.

1 in 4

One in four dogs will develop neoplasia (pre-cancer).

  - American Veterinary Medical Association (AVMA)

50%

Half of all dogs over the age of 10 years will develop cancer.

  - American Veterinary Medical Association (AVMA)

>$4,000

The average cost of a canine cancer treatment exceeds $4,000, despite these drugs being outdated.

- Pets Best database from 2017 to 2021

24.5M

Twenty-four and a half million dollars in claims were made by Nationwide pet insurance members last year on cancer-related conditions.

  - Nationwide

Treat(ments) - Targetted Drug Therapies

Introducing veterinary medicine antibody therapies.

Learn More

Novel Drug Discovery Powered by A.I.

Our cutting-edge technology harnesses the power of generative A.I., revolutionizing the way we predict optimal targeting sites. Unlike any other system, this integrates tertiary and secondary structural data with biochemical information to AIM for our drug targets with unparalleled accuracy and precision.

Monoclonal Antibody

These unique antibodies are designed to mimic the immune system's ability to fight off harmful pathogens or abnormal cells.

Short Peptide

Our short peptide therapies involve the use of small amino acid chains of amino acids, known as peptides, to regulate various biological processes.

Small Molecule

Because of their low molecular weight, small molecule compounds can easily penetrate cell membranes to reach its target.

A.I. Applications for Drug Discovery

Get in touch

We look forward to hearing from you!

bottom of page